Safety and Efficacy of the SurVeil™ Drug-Coated Balloon



Status:Recruiting
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:12/8/2018
Start Date:October 23, 2017
End Date:April 2024
Contact:Shawn Fuller, BS
Email:sfuller@surmodics.com
Phone:952-500-7090

Use our guide to learn which trials are right for you!

The Randomized And Controlled Noninferiority Trial to Evaluate Safety and Clinical Efficacy of the SurVeil™ Drug-Coated Balloon iN the Treatment of Subjects With Stenotic Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT® Admiral® Drug-Coated Balloon

To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment
of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral
and/or popliteal arteries.

TRANSCEND is a prospective, multi-center, single-blind, randomized, controlled,
noninferiority clinical trial. The trial will randomize approximately 446 subjects with
symptomatic PAD due to stenoses of the femoral and/or popliteal arteries. Subjects meeting
eligibility criteria will be randomized 1:1 to treatment with either the SurVeil DCB or the
IN.PACT Admiral DCB, and followed for 60 months.

Inclusion Criteria:

- Subject is ≥18 years.

- Subject has target limb Rutherford classification 2, 3 or 4.

- Subject has provided written informed consent and is willing to comply with study
follow-up requirements.

- De novo lesion(s) or non-stented restenotic lesion(s) occurring >90 days after prior
plain old balloon (POBA) angioplasty or >180 days after prior DCB treatment.

- Target lesion location starts ≥10 mm below the common femoral bifurcation and
terminates distally at or above the end of the P1 segment of the popliteal artery.

- Target vessel diameter ≥4 mm and ≤7 mm.

- Target lesion must have angiographic evidence of ≥70% stenosis by operator visual
estimate.

- Chronic total occlusions may be included only after successful, uncomplicated wire
crossing of target lesion via an anterograde approach and without the use of
subintimal dissection techniques.

- Target lesion must be ≤180 mm in length (one long lesion or multiple serial lesions)
by operator visual estimate. Note: combination lesions must have a total lesion length
of ≤180 mm by visual estimate and be separated by ≤30 mm.

- Target lesion is located at least 30 mm from any stent, if target vessel was
previously stented.

- Successful, uncomplicated (without use of a crossing device) wire crossing of target
lesion. Successful crossing of the target lesion occurs when the tip of the guide wire
is distal to the target lesion without the occurrence of flow-limiting dissection or
perforation and is judged by visual inspection to be within the true lumen.

- After pre-dilatation, the target lesion is ≤70% residual stenosis, absence of a flow
limiting dissection and treatable with available device matrix.

- A patent inflow artery free from significant stenosis (≥50% stenosis) as confirmed by
angiography.

- At least one patent native outflow artery to the ankle or foot, free from significant
stenosis (≥50% stenosis) as confirmed by angiography.

Exclusion Criteria:

- Subject has acute limb ischemia.

- Subject underwent percutaneous transluminal angioplasty (PTA) of the target limb using
plain old balloon angioplasty (POBA) or a stent within the previous 90 days.

- Subject underwent any lower extremity percutaneous treatment using a
paclitaxel-eluting stent or a DCB within the previous 90 days.

- Subject underwent PTA of the target lesion using a DCB within the previous 180 days.

- Subject has had prior vascular intervention in the contralateral limb within 14 days
before the planned study index procedure or subject has planned vascular intervention
in the contralateral limb within 30 days after the index procedure.

- Subject is pregnant, breast-feeding or intends to become pregnant during the time of
the study.

- Subject has life expectancy less than 2 years.

- Subject has a known allergy to contrast medium that cannot be adequately
pre-medicated.

- Subject is allergic to ALL antiplatelet treatments.

- Subject has impaired renal function (i.e. serum creatinine level ≥2.5 mg/dL).

- Subject is dialysis dependent.

- Subject is receiving immunosuppressant therapy.

- Subject has known or suspected active infection at the time of the index procedure.

- Subject has platelet count <100,000/mm3 or >700,000/mm3.

- Subject has history of gastrointestinal hemorrhage requiring a transfusion within 3
months prior to the study procedure.

- Subject is diagnosed with coagulopathy that precludes treatment with systemic
anticoagulation and/or dual antiplatelet therapy (DAPT).

- Subject has history of stroke within the past 90 days.

- Subject has a history of myocardial infarction within the past 30 days.

- Subject is unable to tolerate blood transfusions because of religious beliefs or other
reasons.

- Subject is incarcerated, mentally incompetent, or abusing drugs or alcohol.

- Subject is participating in another investigational drug or medical device study that
has not completed primary endpoint(s) evaluation or that clinically interferes with
the endpoints from this study, or subject is planning to participate in such studies
prior to the completion of this study.

- Subject has had any major (e.g. cardiac, peripheral, abdominal) surgical procedure or
intervention unrelated to this study within 30 days prior to the index procedure or
has planned major surgical procedure or intervention within 30 days of the index
procedure.

- Subject had previous bypass surgery of the target lesion.

- Subject had previous treatment of the target vessel with thrombolysis or surgery.

- Subject is unwilling or unable to comply with procedures specified in the protocol or
has difficulty or inability to return for follow-up visits as specified by the
protocol.

- Target lesion has moderate to severe calcification or was previously treated with a
DCB for moderate to severe calcification (as defined by the PARC classification of
calcification).

- Target lesion involves an aneurysm or is adjacent to an aneurysm (within 5 mm).

- Target lesion requires treatment with alternative therapy such as stenting, laser,
atherectomy, cryoplasty, brachytherapy, re-entry devices, or subintimal dissection
techniques.

- Significant target vessel tortuosity or other parameters prohibiting access to the
target lesion.

- Presence of thrombus in the target vessel.

- Iliac inflow disease requiring treatment, unless the iliac artery disease is
successfully treated first during the index procedure. Success is defined as ≤30%
residual diameter stenosis without death or major complications.

- Presence of an aortic, iliac or femoral artificial graft.
We found this trial at
60
sites
New York, New York 10029
Principal Investigator: Reid Ravin, MD
Phone: 212-241-8250
?
mi
from
New York, NY
Click here to add this to my saved trials
9500 Euclid Avenue
Cleveland, Ohio 44106
216.444.2200
Principal Investigator: Sean Lyden, MD
Phone: 216-444-6735
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Ocala, Florida 34471
Principal Investigator: Robert Feldman, MD
Phone: 352-351-7337
?
mi
from
Ocala, FL
Click here to add this to my saved trials
Asheville, North Carolina 28801
Principal Investigator: John Henretta, MD
Phone: 828-213-5631
?
mi
from
Asheville, NC
Click here to add this to my saved trials
Atlanta, Georgia 30309
Principal Investigator: Andrew Klein
Phone: 404-605-2371
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
1364 Clifton Rd NE
Atlanta, Georgia 30322
(404) 712-2000
Principal Investigator: Khusrow Niazi, MD
Phone: 404-712-7683
Emory University Hospital As the largest health care system in Georgia and the only health...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Austin, Texas 78756
Principal Investigator: Roger Gammon, MD
Phone: 512-421-3870
?
mi
from
Austin, TX
Click here to add this to my saved trials
Birmingham, Alabama 35243
Principal Investigator: Gary Roubin, MD
Phone: 205-599-5193
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Bossier City, Louisiana
Principal Investigator: William Eaves, MD
Phone: 319-638-7309
?
mi
from
Bossier City, LA
Click here to add this to my saved trials
Boston, Massachusetts 02135
Principal Investigator: Lawrence Garcia, MD
Phone: 617-789-3041
?
mi
from
Boston, MA
Click here to add this to my saved trials
Boston, Massachusetts 02215
Principal Investigator: Marc Schermerhorn, MD
?
mi
from
Boston, MA
Click here to add this to my saved trials
Camp Hill, Pennsylvania 17011
Principal Investigator: Venkatesh Nadar
Phone: 717-963-8389
?
mi
from
Camp Hill, PA
Click here to add this to my saved trials
Cherry Hill, New Jersey 08034
Principal Investigator: Ibrahim Moussa, MD
Phone: 856-673-1352
?
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Cincinnati, Ohio 45219
Principal Investigator: Sashi Kilaru, MD
Phone: 513-585-1777
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Clearwater, Florida 33756
Principal Investigator: Richard Sola, MD
?
mi
from
Clearwater, FL
Click here to add this to my saved trials
Columbia, South Carolina 29203
Principal Investigator: Mahir Elder, MD
Phone: 803-434-8362
?
mi
from
Columbia, SC
Click here to add this to my saved trials
3535 Olentangy River Road
Columbus, Ohio 43214
Principal Investigator: Michael Jolly, MD
Phone: 614-466-1260
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Covington, Louisiana 70433
Principal Investigator: Frank Arena, MD
Phone: 985-892-2550
?
mi
from
Covington, LA
Click here to add this to my saved trials
800 Biesterfield Road
Elk Grove Village, Illinois 60007
Principal Investigator: Jack Chamberlin, MD
Phone: 847-427-7230
?
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
Elyria, Ohio 44035
Principal Investigator: Naim Farhat, MD
Phone: 440-366-2287
?
mi
from
Elyria, OH
Click here to add this to my saved trials
Foley, Alabama 36535
Principal Investigator: Frank Bunch, MD
Phone: 251-990-1936
?
mi
from
Foley, AL
Click here to add this to my saved trials
Fremont, California
Principal Investigator: Ashit Jain, MD
Phone: 510-792-0222
?
mi
from
Fremont, CA
Click here to add this to my saved trials
743 Spring St NE
Gainesville, Georgia 30501
770-219-9000
Principal Investigator: Jeff Marshall, MD
Phone: 678-989-5001
Northeast Georgia Medical Center Northeast Georgia Health System (NGHS) is a not-for-profit community health system...
?
mi
from
Gainesville, GA
Click here to add this to my saved trials
Gilbert, Arizona 85297
Principal Investigator: George Nseir, MD
Phone: 480-728-8736
?
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Greensboro, North Carolina 27401
Principal Investigator: Wells Brabham, MD
Phone: 336-832-3748
?
mi
from
Greensboro, NC
Click here to add this to my saved trials
Hattiesburg, Mississippi 39401
Principal Investigator: Robert Wilkims, MD
?
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Oscar Rosales, MD
Phone: 713-704-4137
?
mi
from
Houston, TX
Click here to add this to my saved trials
Indianapolis, Indiana 46260
Principal Investigator: Brian Bigelow, MD
Phone: 317-583-6313
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
Principal Investigator: Axel Thors, MD
Phone: 913-558-9691
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials
Kingsport, Tennessee 37660
Principal Investigator: Christopher Metzger, MD
Phone: 423-230-5643
?
mi
from
Kingsport, TN
Click here to add this to my saved trials
Knoxville, Tennessee 37934
Principal Investigator: Malcolm Foster, MD
Phone: 865-218-7535
?
mi
from
Knoxville, TN
Click here to add this to my saved trials
Largo, Florida 33770
Principal Investigator: Merrill Krolick, MD
Phone: 727-489-5416
?
mi
from
Largo, FL
Click here to add this to my saved trials
Lexington, Kentucky 40536
Principal Investigator: Khaled Ziada, MD
Phone: 859-323-4738
?
mi
from
Lexington, KY
Click here to add this to my saved trials
McKinney, Texas 75069
Principal Investigator: Muhammad Khan, MD
Phone: 972-562-2345
?
mi
from
McKinney, TX
Click here to add this to my saved trials
Minneapolis, Minnesota 55407
Principal Investigator: Peter Alden, MD
Phone: 612-863-3793
?
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Naperville, Illinois 65040
Principal Investigator: Mark Goodwin, MD
Phone: 630-785-2241
?
mi
from
Naperville, IL
Click here to add this to my saved trials
20 York St, N20 York St,
New Haven, Connecticut 06520
(203) 688-4242
Principal Investigator: Carlos Mena, MD
Yale-New Haven Hospital Relying on the skill and expertise of more than 4,500 university and...
?
mi
from
New Haven, CT
Click here to add this to my saved trials
1514 Jefferson Hwy.
New Orleans, Louisiana 70121
504-842-3000
Principal Investigator: John Reilly, MD
Phone: 504-842-8092
Ochsner Medical Center Ochsner Medical Center is located near uptown New Orleans and includes acute...
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
New York, New York 10032
Principal Investigator: Sahil Parikh
Phone: 212-342-3485
?
mi
from
New York, NY
Click here to add this to my saved trials
Newark, New Jersey 07102
Principal Investigator: Abbas Shehadeh, MD
?
mi
from
Newark, NJ
Click here to add this to my saved trials
Oklahoma City, Oklahoma 73120
Principal Investigator: Thomas Hennebry, MD
Phone: 405-608-1280
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Omaha, Nebraska 68198
Principal Investigator: Andrew Goldsweig, MD
Phone: 402-559-0996
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Petoskey, Michigan 49770
Principal Investigator: Jason Ricci, MD
Phone: 231-487-9185
?
mi
from
Petoskey, MI
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
Principal Investigator: Timothy Clark, MD
Phone: 215-662-8000
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19141
Principal Investigator: Sean Janzer, MD
Phone: 214-456-7316
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
9205 Southwest Barnes Road
Portland, Oregon 97225
Principal Investigator: Brant Ullery, MD
Phone: 503-215-6746
?
mi
from
Portland, OR
Click here to add this to my saved trials
164 Summit Ave
Providence, Rhode Island 02906
(401) 793-2500
Principal Investigator: Peter Soukas, MD
Phone: 417-820-3622
Miriam Hospital The Miriam Hospital is a private, not-for-profit hospital, with a history of providing...
?
mi
from
Providence, RI
Click here to add this to my saved trials
4420 Lake Boone Trail
Raleigh, North Carolina 27607
Principal Investigator: Ravish Sachar, MD
Phone: 919-784-7851
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
Randwick,
Principal Investigator: Ramon Varcoe, MD
?
mi
from
Randwick,
Click here to add this to my saved trials
Robbinsdale, Minnesota 55422
Principal Investigator: William McMillan, MD
Phone: 612-589-8211
?
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Sioux Falls, South Dakota 57108
Principal Investigator: Michael J Bacharach, MD
Phone: 605-977-5336
?
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Springfield, Illinois 62701
Principal Investigator: Jeffrey Goldstein, MD
Phone: 217-492-9100
?
mi
from
Springfield, IL
Click here to add this to my saved trials
1235 E Cherokee St
Springfield, Missouri 65804
(417) 820-2000
Principal Investigator: Christopher Stout, MD
Phone: 417-820-3622
Mercy Hospital Springfield We're continuing a tradition of healing more than 120 years old. Mercy...
?
mi
from
Springfield, MO
Click here to add this to my saved trials
Teaneck, New Jersey 07666
Principal Investigator: John Rundback, MD
?
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Toledo, Ohio 43614
Principal Investigator: Mark Burket, MD
Phone: 419-383-3853
?
mi
from
Toledo, OH
Click here to add this to my saved trials
Washington, District of Columbia
Principal Investigator: Nelson Bernardo, MD
Phone: 202-877-7452
?
mi
from
Washington,
Click here to add this to my saved trials
West Des Moines, Iowa 50266
Principal Investigator: David Chew, MD
Phone: 515-633-3847
?
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Wormleysburg, Pennsylvania 17043
Principal Investigator: William Bachinsky, MD
Phone: 717-731-0101
?
mi
from
Wormleysburg, PA
Click here to add this to my saved trials
Wynnewood, Pennsylvania 19096
Principal Investigator: Alexander Uribe, MD
Phone: 484-476-8580
?
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Yuma, Arizona 85364
Principal Investigator: Joseph Cardenas, MD
Phone: 928-941-6898
?
mi
from
Yuma, AZ
Click here to add this to my saved trials